1 (Rabeprazole Sodium Delayed Release Tablets 1)
Rabeprazole Sodium Tablet, Delayed Release
Product Images NDC 65162-724
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rabeprazole Sodium (NDC 65162-724). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
1 (Rabeprazole Sodium Delayed Release Tablets 2)
This is a graphic displaying the mean daytime heartburn scores for a placebo group and groups taking RAB at 10mg and 20mg. The study day is shown on the x-axis and the heartburn scores, ranging from 0 to 4, are shown on the y-axis. The heartburn scores indicate the degree to which the participants experienced heartburn during the day, with 0 being none and 4 being very severe.*
1 (Rabeprazole Sodium Delayed Release Tablets 3)
This is a chart showing the mean nighttime heartburn scores of different treatments in a study. The treatments are a placebo, RAB 10mg, and RAB 20mg. The study lasted for 28 days and the heartburn scores ranged from 0 (no heartburn) to 4 (very severe heartburn).*
1 (Rabeprazole Sodium Delayed Release Tablets 4)
The text describes a figure labeled as "Figure 4" which presents the mean daytime heartburn scores for a study named RAB-USA-3. The scores are presented for different study days, ranging from 0 to 28, and for different treatments, including a placebo. The heartburn scores range from 0 to 4, where 0 indicates no heartburn and 4 indicates very severe heartburn.*
1 (Rabeprazole Sodium Delayed Release Tablets 5)
The image shows the mean nighttime heartburn scores for a study, comparing a placebo group (n=58) to a group taking RAB20mg (n=59). The scores are displayed over time (study days) and range from "None" to "Very Severe".*
10 (Rabeprazole Sodium Delayed Release Tablets 6)
This is a medication guide for Rabeprazole Sodium Delayed-release Tablets, available in a PDF format that can be downloaded or scanned using a QR code. The guide includes instructions for pharmacists to dispense it to each patient. The rest of the text includes illegible or garbled characters and cannot be evaluated.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
